A Recombinase Polymerase Amplification-Coupled Cas12a Mutant-Based Module for Efficient Detection of Streptomycin-Resistant Mutations in Mycobacterium tuberculosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Recombinase Polymerase Amplification-Coupled Cas12a Mutant-Based Module for Efficient Detection of Streptomycin-Resistant Mutations in Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-06
DOI
10.3389/fmicb.2021.796916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of the SARS‐CoV‐2 D614G mutation using engineered Cas12a guide RNA
- (2021) Qingzhou Meng et al. Biotechnology Journal
- A universal CRISPR/Cas12a nucleic acid sensing platform based on proximity extension and transcription-unleashed self-supply crRNA
- (2021) Guozhen Tian et al. ANALYTICA CHIMICA ACTA
- Heterogeneous Streptomycin Resistance Level Among Mycobacterium tuberculosis Strains From the Same Transmission Cluster
- (2021) Deisy M. G. C. Rocha et al. Frontiers in Microbiology
- Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants
- (2021) Helena de Puig et al. Science Advances
- Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP
- (2021) Yaqin Zhang et al. SENSORS AND ACTUATORS B-CHEMICAL
- Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China
- (2020) Md Mahmudul Islam et al. Microbial Drug Resistance
- Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
- (2020) Eszter Tóth et al. NUCLEIC ACIDS RESEARCH
- An isothermal method for sensitive detection of Mycobacterium tuberculosis complex using CRISPR/Cas12a cis- and trans-cleavage
- (2020) Haipo Xu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER
- (2020) Xinjie Wang et al. Science Bulletin
- Engineering of high-precision base editors for site-specific single nucleotide replacement
- (2019) Junjie Tan et al. Nature Communications
- Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study
- (2019) Ankur Gupta-Wright et al. PLOS MEDICINE
- Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing
- (2019) Kingsley King-Gee Tam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China
- (2019) Xinchang Chen et al. Frontiers in Microbiology
- SHERLOCK: nucleic acid detection with CRISPR nucleases
- (2019) Max J. Kellner et al. Nature Protocols
- Cas12a/gRNA-based platform for rapid and accurate identification of major Mycobacterium species
- (2019) Guohui Xiao et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
- (2018) Susan E Dorman et al. LANCET INFECTIOUS DISEASES
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
- (2018) Janice S. Chen et al. SCIENCE
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
- (2018) Jonathan S. Gootenberg et al. SCIENCE
- Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones
- (2018) Honghu Sun et al. Infection and Drug Resistance
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State
- (2017) Joseph Shea et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Novel structural features drive DNA binding properties of Cmr, a CRP family protein in TB complex mycobacteria
- (2017) Sridevi Ranganathan et al. NUCLEIC ACIDS RESEARCH
- The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation
- (2017) Jing Wang et al. Nature Communications
- CRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing
- (2017) Miguel A. Moreno-Mateos et al. Nature Communications
- Mutations in rrs , rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand
- (2016) Nat Smittipat et al. Journal of Global Antimicrobial Resistance
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Rapid Detection of Isoniazid Resistance in Mycobacterium tuberculosis Isolates by Use of Real-Time-PCR-Based Melting Curve Analysis
- (2014) S. Hu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- High resolution melting curve assay for rapid detection of drug-resistant Mycobacterium tuberculosis
- (2013) Yuhki Nagai et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA
- (2008) Luciano A. Marraffini et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started